Tectonic Therapeutic (TECX) Non-Current Assets (2017 - 2026)
Tectonic Therapeutic (TECX) posted quarterly Non-Current Assets of $6.7 million for Q1 2026, up 28.92% year-over-year from $5.2 million in Q1 2025, and up 81.73% quarter-over-quarter from $3.7 million in Q4 2025.
Tectonic Therapeutic (TECX) Non-Current Assets (2017 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has reported Non-Current Assets for 10 consecutive years, with $6.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Non-Current Assets rose 28.92% year-over-year to $6.7 million; the TTM figure through Mar 2026 stood at $18.6 million (down 22.14% YoY), while the FY2025 annual figure was $3.7 million, down 39.17% from the prior year.
- Non-Current Assets climbed to $6.7 million in Q1 2026 per TECX's latest filing, from $3.7 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $8.5 million in Q4 2023 and bottomed at $510000.0 in Q1 2024.
- Historically, Non-Current Assets has averaged $4.7 million across 5 years, with a median of $4.5 million in 2025.
- Annual changes were most pronounced in 2024 — Non-Current Assets slumped 91.14% — and 2025, when it jumped 916.86%.
- Tectonic Therapeutic's Non-Current Assets stood at $4.0 million in 2022, then surged by 113.36% to $8.5 million in 2023, then retreated by 28.97% to $6.0 million in 2024, then tumbled by 39.17% to $3.7 million in 2025, then soared by 81.73% to $6.7 million in 2026.
- Business Quant data shows TECX's Non-Current Assets at $6.7 million in Q1 2026, $3.7 million in Q4 2025, and $3.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 14.88 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 23.28 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.96 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 294.93 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.96 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.76 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 18.06 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 938.60 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 468.65 Mn |
| 10 | Tectonic Therapeutic | 671.50 Mn | 671.50 Mn | - | 5.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.94 Mn |
| Mar 31, 2026 | 6.69 Mn |
| Dec 31, 2025 | 3.68 Mn |
| Sep 30, 2025 | 3.76 Mn |
| Jun 30, 2025 | 4.47 Mn |
| Mar 31, 2025 | 5.19 Mn |
| Dec 31, 2024 | 6.05 Mn |
| Sep 30, 2024 | 6.12 Mn |
| Jun 30, 2024 | 6.52 Mn |
| Mar 31, 2024 | 510,000.00 |
| Dec 31, 2023 | 8.52 Mn |
| Sep 30, 2023 | 1.35 Mn |
| Jun 30, 2023 | 4.99 Mn |
| Mar 31, 2023 | 5.75 Mn |
| Dec 31, 2022 | 3.99 Mn |
| Sep 30, 2022 | 3.26 Mn |
| Jun 30, 2022 | 4.16 Mn |
| Mar 31, 2022 | 4.42 Mn |
| Dec 31, 2021 | 4.69 Mn |
| Sep 30, 2021 | 4.80 Mn |